JP2003510285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003510285A5 JP2003510285A5 JP2001526187A JP2001526187A JP2003510285A5 JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5 JP 2001526187 A JP2001526187 A JP 2001526187A JP 2001526187 A JP2001526187 A JP 2001526187A JP 2003510285 A5 JP2003510285 A5 JP 2003510285A5
- Authority
- JP
- Japan
- Prior art keywords
- echinacea
- amount
- composition
- chinacea
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000258180 Echinacea <Echinodermata> Species 0.000 claims 21
- 235000014134 echinacea Nutrition 0.000 claims 21
- 150000004676 glycans Polymers 0.000 claims 10
- 229920001282 polysaccharide Polymers 0.000 claims 10
- 239000005017 polysaccharide Substances 0.000 claims 10
- 150000004804 polysaccharides Polymers 0.000 claims 10
- 239000002253 acid Substances 0.000 claims 8
- -1 alkyl amide Chemical class 0.000 claims 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 1
Claims (9)
- 約0.2mg/mlから約500mg/mlのシコリイン酸、約0.02mg/mlから約50mg/mlのEchinaceaアルキルアミドおよび約10mg/mlから約800mg/mlのEchinaceaポリサッカライドを含む、Echinacea組成物。
- 前記シコリイン酸の量が、約0.3mg/mlから約30mg/mlであり、前記Echinaceaアルキルアミドの量が、約0.05mg/mlから約50mg/mlであり、そして前記Echinaceaポリサッカライドの量が、約20mg/mlから約800mg/mlである、請求項1に記載のEchinacea組成物。
- 前記シコリイン酸の量が、約5.0mg/mlから約30mg/mlであり、前記Echinaceaアルキルアミドの量が、約0.8mg/mlから約50mg/mlであり、そして前記Echinaceaポリサッカライドの量が、約50mg/mlから約800mg/mlである、請求項2に記載のEchinacea組成物。
- 約0.01mg/gから約500mg/gのシコリイン酸、約0.005mg/gから約100mg/gのEchinaceaアルキルアミドおよび約5mg/gから約900mg/gのEchinaceaポリサッカライドを含む、Echinacea組成物。
- 前記シコリイン酸の量が、約0.05mg/gから約500mg/gであり、前記Echinaceaアルキルアミドの量が、約0.1mg/gから約100mg/gであり、そして前記Echinaceaポリサッカライドの量が、約10mg/gから約900mg/gである、請求項4に記載のEchinacea組成物。
- 前記シコリイン酸の量が、約15mg/gから約500mg/gであり、前記Echinaceaアルキルアミドの量が、約5mg/gから約100mg/gであり、そして前記Echinaceaポリサッカライドの量が、約200mg/gから約900mg/gである、請求項4に記載のEchinacea組成物。
- 前記組成物が、固体またはゲルである、請求項4に記載のEchinacea組成物。
- Echinacea組成物を調製するための方法であって、該方法は、ある量のシコリイン酸、ある量のEchinaceaアルキルアミドおよびある量のEchinaceaポリサッカライドを混合して、約0.2mg/mlから約500mg/mlのシコリイン酸、約0.02mg/mlから約50mg/mlのEchinaceaアルキルアミドおよび約10mg/mlから約800mg/mlのEchinaceaポリサッカライドを含むEchinacea組成物を生じる工程を包含する、方法。
- Echinacea組成物を調製するための方法であって、該方法は、ある量のシコリイン酸、ある量のEchinaceaアルキルアミドおよびある量のEchinaceaポリサッカライドを混合して、約0.01mg/gから約500mg/gのシコリイン酸、約0.005mg/gから約100mg/gのEchinaceaアルキルアミドおよび約5mg/gから約900mg/gのEchinaceaポリサッカライドを含むEchinacea組成物を生じる工程を包含する、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15719499P | 1999-09-30 | 1999-09-30 | |
US60/157,194 | 1999-09-30 | ||
PCT/CA2000/000931 WO2001022977A2 (en) | 1999-09-30 | 2000-08-11 | Echinacea supplement and method of manufacture |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2003510285A JP2003510285A (ja) | 2003-03-18 |
JP2003510285A5 true JP2003510285A5 (ja) | 2005-09-29 |
JP4559683B2 JP4559683B2 (ja) | 2010-10-13 |
Family
ID=22562708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001526187A Expired - Fee Related JP4559683B2 (ja) | 1999-09-30 | 2000-08-11 | Echinaceaサプリメントおよびその製造方法 |
Country Status (14)
Country | Link |
---|---|
US (2) | US6511683B1 (ja) |
EP (1) | EP1220680B1 (ja) |
JP (1) | JP4559683B2 (ja) |
CN (1) | CN1240403C (ja) |
AT (1) | ATE388718T1 (ja) |
AU (1) | AU777453B2 (ja) |
CA (1) | CA2379581C (ja) |
DE (1) | DE60038308T2 (ja) |
DK (1) | DK1220680T3 (ja) |
ES (1) | ES2303512T3 (ja) |
HK (1) | HK1048943B (ja) |
NZ (1) | NZ517371A (ja) |
PT (1) | PT1220680E (ja) |
WO (1) | WO2001022977A2 (ja) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1278533A2 (en) * | 2000-05-05 | 2003-01-29 | Bioniche Life Sciences Inc. | Use of echinacea as a hematinic agent |
US6746697B2 (en) * | 2000-12-15 | 2004-06-08 | Phytos, Inc. | Composition containing Heliopsis longipes root extract and oral carrier |
EP1297751A1 (de) * | 2001-10-01 | 2003-04-02 | Bogar AG | Oral zu verabreichende Zubereitung |
NZ515182A (en) * | 2001-10-31 | 2004-03-26 | Brightwater Horticulture Ltd | Extraction of biologically active compounds from plant material using acid and antioxidant |
ITMI20021692A1 (it) * | 2002-07-30 | 2002-10-29 | Indena Spa | Polisaccaride di echinacea angustifolia. |
ITMI20021691A1 (it) * | 2002-07-30 | 2004-01-30 | Indena Spa | Estratti di echinacea angustifolia |
EP1613206A2 (en) * | 2003-04-16 | 2006-01-11 | The University Of Mississippi | Immunostimulatory agents in botanicals |
CN1297568C (zh) * | 2003-08-08 | 2007-01-31 | 吉林威威药业股份有限公司 | 一种松果菊多糖、其制备方法及其在制备治疗抗病毒、抗菌及抗sars药物上的用途 |
US20050175721A1 (en) * | 2004-02-06 | 2005-08-11 | Brovelli Ernesto A. | Method of augmenting the immune-modulatory activity of standardized Echinacea preparations |
US8003136B2 (en) * | 2004-03-03 | 2011-08-23 | Randy Beavers | Standardization of botanical products utilizing biological activity as a marker |
AU2005259854C1 (en) * | 2004-07-07 | 2011-06-02 | Integria Healthcare (Australia) PTY LTD | An Echinacea formulation |
WO2006002493A1 (en) * | 2004-07-07 | 2006-01-12 | Mediherb Holdings Ltd | An echinacea formulation |
US8062686B2 (en) * | 2005-04-12 | 2011-11-22 | InovoBiologics, Inc. | Dietary supplement, and methods of use |
US8597709B2 (en) | 2005-04-12 | 2013-12-03 | Inovobiologic Inc. | Dietary supplement and methods of use |
US7491414B2 (en) * | 2005-10-12 | 2009-02-17 | Gaia Herbs, Inc. | Anti-inflammatory substances extracted from Echinacea |
US7829098B2 (en) * | 2005-11-08 | 2010-11-09 | Vita Green Health Products Co., Ltd | Herbal powder extracts and methods of preparing and using the same |
CA2632607A1 (en) * | 2005-12-09 | 2007-06-21 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
CN101032541B (zh) * | 2006-07-28 | 2011-05-11 | 成都地奥九泓制药厂 | 一种紫锥菊提取物及其制备方法和含量测定方法 |
CH699653B1 (de) * | 2008-09-08 | 2010-05-14 | Bioforce Ag Roggwil Tg | Zubereitung zur Prävention und/oder Behandlung und/oder Verhinderung der Weiterverbreitung von Atemwegserkrankungen. |
US8273385B1 (en) | 2008-10-17 | 2012-09-25 | Thres Flo, LLC | Oral rinse composition and method |
CN103906510A (zh) * | 2011-10-11 | 2014-07-02 | Elc管理公司 | 用于处理皮肤的方法和组合物 |
US8920855B1 (en) | 2012-10-30 | 2014-12-30 | Setem Hemth, Inc | Methods of topically treating tinnitus and related disorders |
KR20220125370A (ko) * | 2013-03-14 | 2022-09-14 | 마리 케이 인코포레이티드 | 화장품 조성물들 |
EP3335716A1 (en) * | 2016-12-15 | 2018-06-20 | Indena S.p.A. | Process for the preparation of powder compositions |
DE102017206827A1 (de) | 2017-04-24 | 2018-10-25 | Roman Gehre | Gewinnung und Nutzung von Polyphenolen, insbesondere Cichoriensäure, aus Pflanzen der Gattung Posidonia |
JP7488573B2 (ja) | 2021-01-14 | 2024-05-22 | 株式会社山田養蜂場本社 | マクロファージ活性剤 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0213099A3 (de) * | 1985-08-23 | 1989-07-19 | Cederroth Nordic Aktiebolag | Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen |
DE3744571A1 (de) * | 1987-12-30 | 1989-07-13 | Lohmann Rudolf Lomapharm | Pharmazeutische zubereitungen zur stimulierung des immunsystems und verfahren zu ihrer herstellung |
DE3744570A1 (de) * | 1987-12-30 | 1989-07-13 | Lohmann Rudolf Lomapharm | Pharmazeutische zubereitungen mit immunstimulierender wirkung und verfahren zu ihrer herstellung |
CH676931A5 (en) * | 1988-08-02 | 1991-03-28 | Spagyros S A | Herbal medicaments prodn. - contg. essential antimicrobial oils and Echinacea tinctures, for treating infections, etc. |
ES2075187T3 (es) * | 1990-07-05 | 1995-10-01 | Indena Spa | Extractos de equinaceas, un procedimiento para su preparacion y formulaciones que los contienen. |
US6355684B1 (en) * | 1990-10-11 | 2002-03-12 | Meryl J. Squires | Antimicrobial treatment for herpes simplex virus and other infectious diseases |
US5455033A (en) * | 1993-05-21 | 1995-10-03 | Degree/Silverman M.D. Inc. | Medicinal composition for treatment of inflammation |
FR2742987B1 (fr) * | 1996-01-03 | 1998-04-03 | Lvmh Rech | Utilisation dans le domaine de la cosmetique et de la pharmacie, notamment de la dermatologie, d'un extrait d'eriobotrya japonica pour stimuler la synthese des glycosaminoglycanes |
US6261565B1 (en) | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
CA2307614A1 (en) * | 1997-10-23 | 1999-04-29 | Elliot P. Friedman | Pharmaceutical grade echinacea |
US6217878B1 (en) * | 1999-08-13 | 2001-04-17 | Amway Corporation | Method of preparing echinacea powder |
-
2000
- 2000-08-11 EP EP00954190A patent/EP1220680B1/en not_active Expired - Lifetime
- 2000-08-11 DE DE60038308T patent/DE60038308T2/de not_active Expired - Lifetime
- 2000-08-11 DK DK00954190T patent/DK1220680T3/da active
- 2000-08-11 CN CNB008132003A patent/CN1240403C/zh not_active Expired - Fee Related
- 2000-08-11 JP JP2001526187A patent/JP4559683B2/ja not_active Expired - Fee Related
- 2000-08-11 PT PT00954190T patent/PT1220680E/pt unknown
- 2000-08-11 CA CA2379581A patent/CA2379581C/en not_active Expired - Lifetime
- 2000-08-11 WO PCT/CA2000/000931 patent/WO2001022977A2/en active IP Right Grant
- 2000-08-11 NZ NZ517371A patent/NZ517371A/en not_active IP Right Cessation
- 2000-08-11 ES ES00954190T patent/ES2303512T3/es not_active Expired - Lifetime
- 2000-08-11 AU AU66743/00A patent/AU777453B2/en not_active Expired
- 2000-08-11 AT AT00954190T patent/ATE388718T1/de active
- 2000-09-28 US US09/672,729 patent/US6511683B1/en not_active Expired - Lifetime
-
2002
- 2002-11-22 US US10/303,643 patent/US20030152653A1/en not_active Abandoned
-
2003
- 2003-02-18 HK HK03101196.7A patent/HK1048943B/zh not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003510285A5 (ja) | ||
JP2005516946A5 (ja) | ||
JP2004535456A5 (ja) | ||
JP2003506345A5 (ja) | ||
JP2005520796A5 (ja) | ||
JP2003503454A5 (ja) | ||
JP2003520232A5 (ja) | ||
DE60022230D1 (de) | Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv | |
JP2005511782A5 (ja) | ||
TWI317736B (en) | Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications | |
DE69922880D1 (de) | Enzymzusammensetzungen, die in vivo Oligosaccharide bilden können | |
JP2003508328A5 (ja) | ||
HUP0202880A2 (hu) | Nyújtott felszabadulású készítmények, eljárás előállításukra és alkalmazásuk | |
NO20032371L (no) | Makrolidsolvater | |
JO2249B1 (en) | A compound of 6.3-dialkyl-6.5-dihydro-4-hydroxy-biran-2-one | |
JP2006505391A5 (ja) | ||
CA2438622A1 (en) | Compositions containing creatine and creatinine | |
ME00568A (en) | Ciclesonide-containing aqueous pharmaceutical composition | |
EA200600173A1 (ru) | Диспергируемая во рту фармацевтическая композиция антитромботического соединения | |
YU49435B (sh) | Postupak za dobijanje kompaktiranih sipkavih sirovina za lakove | |
JP2000109457A5 (ja) | ||
JP2004526429A5 (ja) | ||
NO20023975D0 (no) | Fremgangsmåte for fremstilling av metallkompleks av aminooligosakkaridderivat | |
JP2004517145A5 (ja) | ||
DE50105577D1 (de) | Ribavirin-granulat zur herstellung von filmtabletten |